Issues pertaining to Medicare reimbursement. Issues pertaining to drug shortages, legislation regarding the 340B Drug discount program. Issues pertaining to sequestration; Issues related to pharmacy benefit managers. Drug Pricing legislation. Monitoring CMMI Demonstration Projects. CON regulations. CARES implementation.
2025 · 2nd Quarter (Apr 1 - June 30)
ONEONCOLOGY LLC
Filed by FARRAGUT PARTNERS LLP.
Open official filingSource-reported fields
Filing overview
- Type
- 2nd Quarter - Report
- Posted
- Jul 21, 2025
- Income
- $50,000.00
- Expenses
- Not reported
- Registrant
- FARRAGUT PARTNERS LLP
- Client
- ONEONCOLOGY LLC
- Filing UUID
- 36e7c4ce-5021-43d0-9d3b-2a48aa554dc6
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Issues pertaining to Medicare reimbursement. Issues pertaining to drug shortages, legislation regarding the 340B Drug discount program. Issues pertaining to sequestration; Issues related to pharmacy benefit managers. Drug Pricing legislation. Monitoring CMMI Demonstration Projects. CON regulations. CARES implementation
Issues related to pharmacy benefit managers.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.